|Articles|February 1, 1997
Supplements and Featured Publications
- Looking Beyond the Formulary Budget: Cost Analysis and a Psychiatric Perspective
- Volume 3
- Issue 2 Suppl
Participants
Advertisement
Articles in this issue
about 29 years ago
Introduction: Looking Beyond the Formulary Budgetabout 29 years ago
Evaluating the Cost Effectiveness of Newer Psychotropic Medicationsabout 29 years ago
Looking Beyond the Formulary Budget in Cost-Benefit Analysisabout 29 years ago
Retrospective Analysis of the Effect of Risperidone on Clinical Outcomeabout 29 years ago
Newer Antipsychotic Medications: Discussionsabout 29 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
5 Things to Know About the Oral GLP-1 Era
5
